Ing‐Jun Chen

652 total citations
27 papers, 591 citations indexed

About

Ing‐Jun Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Ing‐Jun Chen has authored 27 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Physiology. Recurrent topics in Ing‐Jun Chen's work include Nitric Oxide and Endothelin Effects (8 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Receptor Mechanisms and Signaling (5 papers). Ing‐Jun Chen is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Receptor Mechanisms and Signaling (5 papers). Ing‐Jun Chen collaborates with scholars based in Taiwan, Czechia and United States. Ing‐Jun Chen's co-authors include Jwu‐Lai Yeh, Jyh‐Chong Liang, Yi‐Ching Lo, Jong‐Hau Hsu, Che‐Ming Teng, Jaw‐Jou Kang, Chun-Nan Lin, Sheng‐Nan Wu, Yang‐Chang Wu and Bin‐Nan Wu and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Ing‐Jun Chen

27 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ing‐Jun Chen Taiwan 16 282 123 105 92 90 27 591
Sheu‐Meei Yu Taiwan 15 418 1.5× 114 0.9× 162 1.5× 91 1.0× 90 1.0× 22 839
Robert A. Forder United Kingdom 14 379 1.3× 67 0.5× 112 1.1× 150 1.6× 29 0.3× 29 890
Chiu‐Yin Kwan Canada 12 186 0.7× 41 0.3× 89 0.8× 69 0.8× 72 0.8× 20 435
Madhur Ray India 10 167 0.6× 43 0.3× 72 0.7× 46 0.5× 41 0.5× 16 491
Azza A. Ali Egypt 16 165 0.6× 47 0.4× 91 0.9× 59 0.6× 34 0.4× 59 589
Net Daş-Evcimen Türkiye 9 245 0.9× 95 0.8× 124 1.2× 65 0.7× 57 0.6× 15 623
Roberta Caporaso Italy 10 281 1.0× 99 0.8× 92 0.9× 149 1.6× 83 0.9× 11 501
H Ozaki Japan 4 340 1.2× 29 0.2× 252 2.4× 45 0.5× 135 1.5× 7 702
Haruhiko Sakiyama Japan 14 401 1.4× 50 0.4× 103 1.0× 38 0.4× 32 0.4× 28 761
Luchen Shan China 19 390 1.4× 44 0.4× 68 0.6× 130 1.4× 111 1.2× 49 861

Countries citing papers authored by Ing‐Jun Chen

Since Specialization
Citations

This map shows the geographic impact of Ing‐Jun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ing‐Jun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ing‐Jun Chen more than expected).

Fields of papers citing papers by Ing‐Jun Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ing‐Jun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ing‐Jun Chen. The network helps show where Ing‐Jun Chen may publish in the future.

Co-authorship network of co-authors of Ing‐Jun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ing‐Jun Chen. A scholar is included among the top collaborators of Ing‐Jun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ing‐Jun Chen. Ing‐Jun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hsu, Jong‐Hau, et al.. (2011). San-Huang-Xie-Xin-Tang protects cardiomyocytes against hypoxia/reoxygenation injury via inhibition of oxidative stress-induced apoptosis. Journal of Natural Medicines. 66(2). 311–320. 44 indexed citations
3.
Hsieh, Chong‐Chao, Chee‐Yin Chai, Arco Y. Jeng, et al.. (2010). Protective effects of a dual endothelin converting enzyme/neutral endopeptidase inhibitor on the development of pulmonary hypertension secondary to cardiac dysfunction in the rat. Pediatric Pulmonology. 45(11). 1076–1085. 1 indexed citations
4.
Liang, Jyh‐Chong, et al.. (2010). San‐Huang‐Xie‐Xin‐Tang Prevents Rat Hearts from Ischemia/Reperfusion‐Induced Apoptosis through eNOS and MAPK Pathways. Evidence-based Complementary and Alternative Medicine. 2011(1). 915051–915051. 26 indexed citations
5.
Yeh, Jwu‐Lai, et al.. (2010). KMUP‐1 attenuates isoprenaline‐induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathways. British Journal of Pharmacology. 159(5). 1151–1160. 40 indexed citations
8.
Yeh, Jwu‐Lai, et al.. (2005). Labedipinedilol-C: A Third-Generation Dihydropyridine-Type Calcium Channel Antagonist Displaying K+ Channel Opening, NO-Dependent and Adrenergic Antagonist Activities. Journal of Cardiovascular Pharmacology. 46(2). 130–140. 8 indexed citations
9.
Yeh, Jwu‐Lai, et al.. (2004). Inhibition of Mitogen-Mediated Proliferation of Rat Vascular Smooth Muscle Cells by Labedipinedilol-A through PKC and ERK 1/2 Pathway. Journal of Cardiovascular Pharmacology. 44(5). 539–551. 26 indexed citations
10.
Lo, Yi‐Ching, et al.. (2004). San-Huang-Xie-Xin-Tang reduces lipopolysaccharides-induced hypotension and inflammatory mediators. Journal of Ethnopharmacology. 96(1-2). 99–106. 37 indexed citations
11.
Lo, Yi‐Ching, et al.. (2003). A Novel Capsaicin Derivative VOA Induced Relaxation in Rat Mesenteric and Aortic Arteries. Journal of Cardiovascular Pharmacology. 42(4). 511–520. 20 indexed citations
13.
Kang, Jaw‐Jou, et al.. (2002). Antihypertensive and vasorelaxing activities of synthetic xanthone derivatives. Bioorganic & Medicinal Chemistry. 10(3). 567–572. 64 indexed citations
14.
Yeh, Jwu‐Lai, et al.. (2001). A new aspect of view in synthesizing new type β-adrenoceptor blockers with ancillary antioxidant activities. Bioorganic & Medicinal Chemistry. 9(7). 1739–1746. 14 indexed citations
15.
Yeh, Jwu‐Lai, et al.. (2000). Vanidipinedilol: A Vanilloid-Based β-Adrenoceptor Blocker Displaying Calcium Entry Blocking and Vasorelaxant Activities. Journal of Cardiovascular Pharmacology. 35(1). 51–63. 26 indexed citations
16.
Yeh, Jwu‐Lai, et al.. (2000). Isoeugenodilol: A vasorelaxant ?/?-adrenoceptor blocker with antioxidant activity. Drug Development Research. 51(1). 29–42. 11 indexed citations
17.
Yang, Yu‐Chiao, et al.. (1999). Nitrated nonivamide displaying a drawback of proton's role in capsaicin-associated sensory and neuronal activities. General Pharmacology The Vascular System. 33(3). 257–269. 2 indexed citations
18.
Wu, Sheng‐Nan, Hui-Fang Li, Chung-Ren Jan, Ing‐Jun Chen, & Yi‐Ching Lo. (1998). Selective block by glyceryl nonivamide of inwardly rectifying K+ current in rat anterior pituitary GH3 cells. Life Sciences. 63(19). PL281–PL288. 14 indexed citations
19.
Yu, Kwong‐Leung, et al.. (1996). Sodium nonivamide acetate: A non-pungently antinociceptive capsaicin derivative with unusual anti-inflammatory properties. General Pharmacology The Vascular System. 27(1). 141–150. 5 indexed citations
20.
Chen, Ing‐Jun, et al.. (1994). Guaiacoxypropanolamine Derivatives of Capsaicin: A New Family of .beta.-Adrenoceptor Blockers with Intrinsic Cardiotonic Properties. Journal of Medicinal Chemistry. 37(7). 938–943. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026